Price T Rowe Associates Inc Celcuity Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,721 shares of CELC stock, worth $167,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,721Holding current value
$167,281% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CELC
# of Institutions
104Shares Held
30MCall Options Held
17.5KPut Options Held
100-
Bvf Inc San Francisco, CA3.47MShares$45.6 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$35.2 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$33.7 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$31.1 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$21.7 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $196M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...